Top compounds associated with response to SPRR2E


Feature Type Standardized
Nominal ANOVA
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC -0.035 0.2
mRNA erismodegib CTRPv2 pan-cancer AAC -0.045 0.3
mRNA myriocin CTRPv2 pan-cancer AAC 0.088 0.3
mRNA GSK-650394 GDSC1000 pan-cancer AAC 0.042 0.3
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.04 0.3
mRNA TW 37 GDSC1000 pan-cancer AAC 0.038 0.3
mRNA SB52334 GDSC1000 pan-cancer AAC -0.038 0.3
mRNA MK-2206 CTRPv2 pan-cancer AAC 0.042 0.3
mRNA KU-55933 CTRPv2 pan-cancer AAC 0.042 0.3
mRNA Erlotinib CTRPv2 pan-cancer AAC 0.04 0.3
Download CSV